Drug Database
H01CB02 octreotide
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Octreotide 100 microgram/ml, solution for injection/infusion
- POM Octreotide 100 micrograms/1ml Solution for Injection
- POM Octreotide 100microgram / ml solution for injection
- POM Octreotide 200 micrograms/ml solution for injection
- POM Octreotide 200 micrograms/ml Solution for injection
- POM Octreotide 50 micrograms/1 ml Solution for Injection
- POM Octreotide 50 micrograms/ml solution for injection
- POM Octreotide 500 micrograms/1 ml Solution for Injection
- POM Octreotide 500micrograms / ml solution for injection
- POM Olatuton 10 mg Powder and Solvent for Prolonged-release Suspension for Injection
- POM Olatuton 20 mg Powder and Solvent for Prolonged-release Suspension for Injection
- POM Olatuton 30 mg Powder and Solvent for Prolonged-release Suspension for Injection
- POM Sandostatin 50, 100, 500 microgram/1 ml solution for injection/infusion
- POM Sandostatin LAR
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).